Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|July 25, 2018
No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B InfectionAndrea L Cathcart, Henry Lik-Yuen Chan, Neeru Bhardwaj, et al.Alimentary Pharmacology & Therapeutics|November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis BJosef Wagner, Lilly Yuen, Margaret Littlejohn, et al.Journal of Hepatology|January 22, 2017
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcomeStefan Zeuzem, Masashi Mizokami, Stephen Pianko, et al.Journal of Hepatology|April 29, 2023
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis deltaJulius Hollnberger, Yang Liu, Simin Xu, et al.Journal of Hepatology|August 12, 2018
No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patientsChristoph Sarrazin, Curtis L Cooper, Michael P Manns, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2014
Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trialsEvguenia S Svarovskaia, Hadas Dvory-Sobol, Neil Parkin, et al.AIDS (London, England)|September 29, 2021
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individualsBrian Moldt, Huldrych F Günthard, Kimberly A Workowski, et al.Biorxiv : the Preprint Server for Biology|November 16, 2022
Towards increased accuracy and reproducibility in SARS-CoV-2 next generation sequence analysis for public health surveillanceRyan Connor, David A Yarmosh, Wolfgang Maier, et al.Viruses|March 28, 2024
Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic WorkflowsRyan Connor, Migun Shakya, David A Yarmosh, et al.Viruses|April 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE TrialsCharlotte Hedskog, Christoph D Spinner, Ulrike Protzer, et al.Pageof 8